SPAC CEO Awarded Some Defense Fees For Suits, SEC Probe
The founder of a special purpose acquisition company that triggered a U.S. Securities and Exchange Commission investigation after it merged with 180 Life Sciences Corp. is entitled under company bylaws to...To view the full article, register now.
Already a subscriber? Click here to view full article